FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years - Endpoints News

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News

6 July 2026

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years Endpoints News
FDA Approvals Are up, But Timing Is a Challenge in 2026 Medical Device and Diagnostic industry
Regulatory Actions for June 2026 PharmTech.com
FDA Clears More Devices in H1 2026 But Timelines Slip Zenopa
FDA News Recap: Novel Drug Approvals in Q2 2026 HCPLive